| Visionworks | |
| 4301 Wisconsin Ave Nw, Washington, District Of Columbia 20016 | |
| (202) 237-8500 |
| Name | Visionworks |
|---|---|
| Organization Name | Visionworks Inc |
| Location | 4301 Wisconsin Ave Nw, Washington, District Of Columbia 20016 |
| Type | Eyewear Supplier (Equipment, not the service) |
| Phone | (202) 237-8500 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market sevelamer carbonate for oral suspension, 0.8g and 2.4g per packet. Watson's sevelamer carbonate for oral suspension product is the generic version of Genzyme's Renvela for Oral Suspension.
Researchers report in the journal Cell Reports a targeted molecular therapy that dramatically reduces the initial development of Non Alcoholic Fatty Liver Disease (NAFLD) in laboratory mouse models of the disease.
In an effort to better understand and develop prevention strategies for drug-induced liver injury, physician-scientists from the Icahn School of Medicine at Mount Sinai have joined the Drug-Induced Liver Injury Network, a National Institutes of Health-funded consortium of only six academic medical centers in the United States.
Hepatitis C virus infection is a major cause of illness and death in the United States and injection drug use is likely fueling many new cases.
American Laser Centers, http://americanlaser.com, the premier provider of aesthetic services in the United States, today invited Illinois clients of the now-closed Hair Today Gone Tomorrow organization to visit American Laser Centers locations for a complementary treatment.
› Verified 7 days ago
| NPI Number | 1083797559 |
| Organization Name | VISIONWORKS, INC. |
| Doing Business As | VISIONWORKS |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 4301 Wisconsin Ave Nw, Washington, DC 20016 |
| Phone Number | 202-237-8500 |
News Archive
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market sevelamer carbonate for oral suspension, 0.8g and 2.4g per packet. Watson's sevelamer carbonate for oral suspension product is the generic version of Genzyme's Renvela for Oral Suspension.
Researchers report in the journal Cell Reports a targeted molecular therapy that dramatically reduces the initial development of Non Alcoholic Fatty Liver Disease (NAFLD) in laboratory mouse models of the disease.
In an effort to better understand and develop prevention strategies for drug-induced liver injury, physician-scientists from the Icahn School of Medicine at Mount Sinai have joined the Drug-Induced Liver Injury Network, a National Institutes of Health-funded consortium of only six academic medical centers in the United States.
Hepatitis C virus infection is a major cause of illness and death in the United States and injection drug use is likely fueling many new cases.
American Laser Centers, http://americanlaser.com, the premier provider of aesthetic services in the United States, today invited Illinois clients of the now-closed Hair Today Gone Tomorrow organization to visit American Laser Centers locations for a complementary treatment.
› Verified 7 days ago
| NPI Number | 1982981205 |
| Organization Name | VISIONWORKS, INC |
| Doing Business As | VISIONWORKS |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 4301 Wisconsin Ave Nw, Washington, DC 20016 |
| Phone Number | 202-237-8500 |
News Archive
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market sevelamer carbonate for oral suspension, 0.8g and 2.4g per packet. Watson's sevelamer carbonate for oral suspension product is the generic version of Genzyme's Renvela for Oral Suspension.
Researchers report in the journal Cell Reports a targeted molecular therapy that dramatically reduces the initial development of Non Alcoholic Fatty Liver Disease (NAFLD) in laboratory mouse models of the disease.
In an effort to better understand and develop prevention strategies for drug-induced liver injury, physician-scientists from the Icahn School of Medicine at Mount Sinai have joined the Drug-Induced Liver Injury Network, a National Institutes of Health-funded consortium of only six academic medical centers in the United States.
Hepatitis C virus infection is a major cause of illness and death in the United States and injection drug use is likely fueling many new cases.
American Laser Centers, http://americanlaser.com, the premier provider of aesthetic services in the United States, today invited Illinois clients of the now-closed Hair Today Gone Tomorrow organization to visit American Laser Centers locations for a complementary treatment.
› Verified 7 days ago
News Archive
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market sevelamer carbonate for oral suspension, 0.8g and 2.4g per packet. Watson's sevelamer carbonate for oral suspension product is the generic version of Genzyme's Renvela for Oral Suspension.
Researchers report in the journal Cell Reports a targeted molecular therapy that dramatically reduces the initial development of Non Alcoholic Fatty Liver Disease (NAFLD) in laboratory mouse models of the disease.
In an effort to better understand and develop prevention strategies for drug-induced liver injury, physician-scientists from the Icahn School of Medicine at Mount Sinai have joined the Drug-Induced Liver Injury Network, a National Institutes of Health-funded consortium of only six academic medical centers in the United States.
Hepatitis C virus infection is a major cause of illness and death in the United States and injection drug use is likely fueling many new cases.
American Laser Centers, http://americanlaser.com, the premier provider of aesthetic services in the United States, today invited Illinois clients of the now-closed Hair Today Gone Tomorrow organization to visit American Laser Centers locations for a complementary treatment.
› Verified 7 days ago
We Work Office Building Type: Durable Medical Equipment & Medical Supplies Supplier Location: 80 M St Se, Washington, District Of Columbia 20003 Phone: (844) 417-8633 | |
Aids Healthcare Foundation Type: Pharmacy Location: 2141 K St Nw, Washington, District Of Columbia 20037 Phone: (202) 293-8695 | |
All N 1 Medical Supplies & Treasure Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3811 Minnesota Ave Ne, Washington, District Of Columbia 20019 Phone: (202) 388-3300 | |
Bellevue Pharmacy Type: Community/Retail Pharmacy Location: 3939 S Capitol St Sw, Washington, District Of Columbia 20032 Phone: (202) 623-4221 | |
Capitol Medical Supply Inc. Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1618 7th St Nw, Washington, District Of Columbia 20001 Phone: (202) 667-1097 |